Fecal Microbiota Transplantation & Heart Failure
Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure.
Interaction between gut microbiome and cardiovascular disease.
Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure.
The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
Xiao-Qing-Long Tang Prevents Cardiomyocyte Hypertrophy, Fibrosis, and the Development of Heart Failure with Preserved Ejection Faction in Rats by Modulating the Composition of the Gut Microbiota.
Microbial Colonization of Germ-Free Mice Restores Neointimal Hyperplasia Development After Arterial Injury.